Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Columbia University
Columbia University
M.D. Anderson Cancer Center
Georgetown University
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Cancer Trials Ireland
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
MEI Pharma, Inc.
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
National Institutes of Health Clinical Center (CC)
Georgetown University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
MedImmune LLC
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Asan Medical Center
M.D. Anderson Cancer Center
Hoag Memorial Hospital Presbyterian
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center